# Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

> clinical trial · VERIFIED · 2026-08-13

Status: RECRUITING · Sponsor: Hideho Okada, MD, PhD · Condition: EGFR Gene Mutation

- Company: Hideho Okada, MD, PhD
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06186401

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.